Rajthanee Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,741	2,739	2,348	3,365	3,118
Other Revenue	28.9	26.09	27.54	26.15	24.28
Revenue	2,770	2,765	2,375	3,392	3,142
Revenue Growth (YoY)	0.20%	16.39%	-29.96%	7.94%	67.35%
Cost of Revenue	2,073	1,897	1,618	1,848	1,684
Gross Profit	697.56	867.42	757.68	1,544	1,458
Selling, General & Admin	317.26	345.18	222.43	244.95	183.46
Operating Expenses	317.26	345.18	222.43	244.95	183.46
Operating Income	380.3	522.25	535.25	1,299	1,274
Interest Expense	-57.7	-52.67	-33.54	-24.48	-5.92
Interest & Investment Income	2.95	10.89	17.24	15.04	2.81
EBT Excluding Unusual Items	325.55	480.47	518.94	1,289	1,271
Pretax Income	325.55	480.47	518.94	1,289	1,271
Income Tax Expense	39.18	-1.95	103.24	255.8	254.92
Earnings From Continuing Operations	286.37	482.42	415.7	1,034	1,016
Minority Interest in Earnings	8.77	10.62	3.97	-4.45	-4.36
Net Income	295.14	493.04	419.67	1,029	1,012
Net Income to Common	295.14	493.04	419.67	1,029	1,012
Net Income Growth	-40.14%	17.48%	-59.22%	1.71%	145.33%
Shares Outstanding (Basic)	293	299	299	299	300
Shares Outstanding (Diluted)	293	299	299	299	300
Shares Change (YoY)	-2.02%	-	0.06%	-0.25%	-0.02%
EPS (Basic)	1.01	1.65	1.40	3.44	3.37
EPS (Diluted)	1.01	1.65	1.40	3.44	3.37
EPS Growth	-38.91%	17.48%	-59.25%	1.96%	145.38%
Free Cash Flow	409.43	-77.99	190.74	571.54	527.23
Free Cash Flow Per Share	1.40	-0.26	0.64	1.91	1.76
Dividend Per Share	0.600	0.700	1.200	2.500	2.700
Dividend Growth	-14.29%	-41.67%	-52.00%	-7.41%	170.00%
Gross Margin	25.18%	31.37%	31.90%	45.52%	46.40%
Operating Margin	13.73%	18.89%	22.53%	38.30%	40.56%
Profit Margin	10.65%	17.83%	17.67%	30.35%	32.21%
Free Cash Flow Margin	14.78%	-2.82%	8.03%	16.85%	16.78%
EBITDA	563.43	678.2	680.72	1,463	1,434
EBITDA Margin	20.34%	24.53%	28.66%	43.12%	45.63%
D&A For EBITDA	183.13	155.96	145.47	163.59	159.33
EBIT	380.3	522.25	535.25	1,299	1,274
EBIT Margin	13.73%	18.89%	22.53%	38.30%	40.56%
Effective Tax Rate	12.04%	-	19.89%	19.84%	20.05%
Revenue as Reported	2,773	2,776	2,393	3,407	3,145

Source: S&P Global Market Intelligence. Standard template. Financial Sources.